USP15 facilitates the progression of bladder cancer by amplifying the activation of the NF-κB signaling pathway
Figure 2.USP15 expression is associated with clinicopathological characteristics in patients with bladder cancer. Increased USP15 expression was significant with (A) tumor size. (B) Node. (C) Metastasis. (D) Stage.